以人群为基础的风湿关节炎队列中心血管预防服务的利用情况
该研究纳入2015年1月1日居住在明尼苏达州八个县之一的所有≥18岁确诊风湿关节炎(RA)患者,按性别、年龄和县与非RA对照1:1匹配,比较两组心血管疾病(CVD)危险因素筛查率。结果显示RA患者糖尿病筛查(HR 1.10)和高血压筛查(HR 1.37)更常见,高脂血症筛查相似(HR 0.99);但无CVD危险因素的RA患者接受糖尿病筛查(HR 0.67)和高脂血症筛查(HR 0.65)的概率低于仅有一种CVD危险因素诊断的非RA患者,高血压筛查两组相似。
要点
- RA患者糖尿病筛查(HR 1.10)和高血压筛查(HR 1.37)较非RA对照更常见。
- RA患者高脂血症筛查与非RA对照相似(HR 0.99)。
- 无CVD危险因素的RA患者糖尿病筛查(HR 0.67)和高脂血症筛查(HR 0.65)概率低于仅有一种CVD危险因素诊断的非RA患者。
核心结论
- RA患者接受CVD预防筛查的比率至少与一般人群相当。
- 以RA作为唯一CVD危险因素的患者接受筛查的可能性更低,尽管其风险相当于或高于传统CVD危险因素。
- 这些发现表明RA患者照护存在改善机会。
研究设计与样本
- 研究纳入2015年1月1日居住在明尼苏达州八个县之一的所有≥18岁确诊RA患者,按性别、年龄和县与非RA对照1:1匹配。
- 研究共纳入1614例RA患者和1599例非RA对照。
- 采用Cox模型比较两组CVD危险因素筛查率,包括糖尿病(即血糖)、高血压(即血压)和高脂血症(即血脂)筛查。
主要发现
- RA患者糖尿病筛查较非RA对照更常见(HR 1.10,95%CI 1.01至1.19)。
- RA患者高血压筛查较非RA对照更常见(HR 1.37,95%CI 1.24至1.52)。
- RA患者高脂血症筛查与非RA对照相似(HR 0.99,95%CI 0.89至1.10)。
- 无CVD危险因素的RA患者接受糖尿病筛查的概率低于仅有一种CVD危险因素诊断的非RA患者(HR 0.67,95%CI 0.57至0.78)。
- 无CVD危险因素的RA患者接受高脂血症筛查的概率低于仅有一种CVD危险因素诊断的非RA患者(HR 0.65,95%CI 0.54至0.79);高血压筛查两组相似。
临床怎么用
- 原文结论未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The objective is to examine utilisation of cardiovascular preventive services in patients with rheumatoid arthritis (RA), compared with a non-RA population, and to examine cardiovascular disease (CVD) screening rates among RA patients without diabetes mellitus (DM), hypertension or hyperlipidaemia to non-RA patients with one of these diagnoses. METHODS: All ≥18-year-old patients with an RA diagnosis living in one of eight Minnesota counties on 1 January 2015 were included and matched (1:1) by sex, age and county to non-RA comparators. Rates of screening for CVD risk factors, including DM (ie, glucose), hypertension (ie, blood pressure) and hyperlipidaemia (ie, lipids), were compared between groups using Cox models. RESULTS: The study included 1614 patients with RA and 1599 non-RA comparators. DM screening was more common among patients with RA (HR: 1.10, 95% CI: 1.01 to 1.19), as was hypertension screening (HR: 1.37, 95% CI: 1.24 to 1.52). Hyperlipidaemia screening in RA was similar to comparators (HR: 0.99, 95% CI: 0.89 to 1.10). Conversely, patients with RA and no CVD risk factors had a lower probability of undergoing diabetes (HR: 0.67, 95% CI: 0.57 to 0.78) and hyperlipidaemia screening (HR: 0.65, 95% CI: 0.54 to 0.79) than non-RA patients with only one CVD risk factor diagnosis. Hypertension screening was similar between both groups. CONCLUSIONS: RA patients undergo CVD preventive screening at rates at least comparable to the general population. However, patients with RA as their sole CVD risk factor were less likely to undergo screenings, despite an equivalent-to-higher risk as the traditional CVD risk factors. These findings demonstrate opportunities for improvement of RA patient care.
引用
- Montes D, Hulshizer CA, Myasoedova E, et al. Utilisation of cardiovascular preventive services in a rheumatoid arthritis population-based cohort. RMD Open. 2023. PMID: 37945289. doi:10.1136/rmdopen-2023-003318
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。